SelectedWorks of John D. Morrey

  • Author Home
  • Browse Subjects
  • Browse Article Types
  • Series Home
photo

Follow

John D. Morrey

Utah State University

  • Director of the Institute for Antiviral Research
  • Research Professor
  • Contact Information
  • Curriculum Vitae [PDF]
  • ADVS 3200 - DSC: Ethical Issues in Genetic Engineering and Biotechnology
  • ADVS 5260: Methods in Biotechnology - Molecular Cloning
  • 2006 - James LeGrand Shupe Achievement Award
  • 2003 - News article in Science citing transgenic research, "Animal models: live and in color", Science 302:1880-1882
  • 2001 - Article in The Chronicles of Higher Education featuring ADVS 3200 course, "Ethical Issues in Biotechnology"
  • 2001 - Invited Participant for Colloquium, "Freedom and Responsibility in the New Genetics", Houston, Texas
  • 2000 - Invited Participant for Colloquium, "Science and the Meaning of It All", Big Sky, Montana
  • 2000 - Co-Chair for Organizing Symposium, Genetically Engineering and Cloning Animals: Science Society and Industry, Park City/Deer Valley, Utah
  • 2000 - News article in Science citing West Nile virus research, "West Nile drugs, vaccine still years away", Science 290:1483
  • 1999 - Co-organizer for Colloquium, "Liberty, Responsibility, and the Challenge of the New Biology", Big Sky, Montana
  • 1998 - Co-Chair for Organizing Symposium, Genetically Engineering and Cloning Animals: Science Society and Industry, Park City/Deer Valley, Utah
  • 1997 - $2,000 Presentation Award, "HBV transgenic mice as a chemotherapeutic model for HBV infection", Second International Conference on Therapies for Viral Hepatitis, Kona, Hawaii
  • 1997 - Article in Newsweek featuring animal cloning, "Spring cloning", Newsweek, June 30, pp. 82-83
  • 1997 - Review article in Science featuring transgenic research, "Firefly gene lights up lab animals from inside out", Science 276:193
  • 1995-1996 USU Honors Professor. Utah State University's Honors Advisory Board
  • 1992 - Editor's review article in Science, "Awakenings...UV light and HIV gene activation", Science 257:1211-1212
  • 1987 - Staff Fellowship Award, National Institutes of Health
  • DigitalCommons@USU
  • Department of Animal and Veterinary Sciences
  • Personal webpage

Search All Sites

RSS Feed

Print this page

Articles «Previous Next»

Enhanced Antiscrapie Effect Using Combination Drug Treatment

D. A. Kocisko
B. Caughey
John D. Morrey, Utah State University
R. E. Race

Article comments

Originally published by the American Society for Microbiology. Publisher's PDF and HTML fulltext available through remote link.

Abstract

Combination treatment with pentosan polysulfate and Fe(III)meso-tetra(4-sulfonatophenyl)porphine in mice beginning 14 or 28 days after scrapie inoculation significantly increased survival times. This increase may be synergistic, implying that the compounds act cooperatively in vivo. Combination therapy may therefore be more effective for treatment of transmissible spongiform encephalopathies and other protein-misfolding diseases.

Suggested Citation

Kocisko, D.A., B. Caughey, J.D. Morrey, and R.E. Race 2006. Enhanced antiscrapie effect using combination drug treatment. Antimicrobial Agents and Chemotherapy. 50: 3447-3449.


Link to Full Text
Find in your library

Share

 
 

This collection is part of the Digital Commons Network

Architecture • Arts and Humanities • Business • Education • Engineering • Law • Life Sciences
Medicine and Health Sciences • Physical Sciences and Mathematics • Social and Behavioral Sciences

Start a Site | FAQ | My Account | Contact Us

SelectedWorks™ is a trademark of bepress.
Copyright 1999-2013 bepress™ All rights reserved.
Terms of Service | Copyright | Privacy